Navigation Links
Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients
Date:5/8/2013

DALLAS, May 8, 2013 /PRNewswire/ --  Michael Cannizzaro , Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs.

Mr. Cannizzaro said, "BHG's outpatient opioid addiction treatment centers address each patient's physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill development.  This expanded service offering demonstrates our commitment to helping each individual patient achieve his/her best functional level in the community."

Kelly Clark , MD, BHG Chief Medical Officer, commented, "Since most patients will be clinically appropriate for either Buprenorphine or Methadone medication, the choice of which medication each patient will try will usually be decided by the patient in consultation with his/her physician.  Most patients will do well on either medication, while a few will only do well on one or the other.  This additional medication option offers a choice for patients, especially those with medical conditions."

BHG's mission is to achieve positive patient outcomes by using medication-assisted treatment at the lowest possible medication dosage combined with behavioral therapy to control medical and behavioral signs of opioid addiction within an outpatient setting. 

About Behavioral Health Group

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services.  BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction.  In doing so, BHG offers patients their best opportunity for a successful recovery.  With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country.  BHG treatment centers are accredited by The Joint Commission.

For more information, phone 214-365-6187, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 


'/>"/>
SOURCE Behavioral Health Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DocuTrac, Inc. Provides Cloud Hosted Solution for Behavioral Health Providers
2. Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
3. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
4. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
5. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
6. Cynosure to Present at UBS Global Healthcare Conference
7. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
8. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
9. BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
10. Cantel Medical To Present At The Bank Of America Merrill Lynch Health Care Conference
11. Smart Water Leadership Summit Focused On Waterborne Disease Prevention in Healthcare Facilities To Be Held In Chicago June 6 & 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... 2017 The global reprocessed ... the top five players accounting for nearly 94% ... are Stryker Sustainability Solutions, Ethicon (Johnson & Johnson), ... VANGUARD AG. Despite the high level of consolidation, ... the prevalence of fierce competition among the key ...
(Date:3/23/2017)... -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) today ... Phase 1 study of MM-310 in solid tumors. MM-310 ... taxane and targets the EphA2 receptor, a protein which ... tumor types, including prostate, ovarian, bladder, gastric, pancreatic and ... is an important step in evaluating MM-310,s safety and ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... ... 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce a ... solid foundation. As experts in dangerous situations the Inflow IQ team can help ... deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):